- Home
- SNY vs BX Comparison
SNY vs BX Comparison
Compare SNY & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- BX
- Stock Information
- Founded
- SNY 1994
- BX 1985
- Country
- SNY France
- BX United States
- Employees
- SNY N/A
- BX N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- BX Investment Managers
- Sector
- SNY Health Care
- BX Finance
- Exchange
- SNY Nasdaq
- BX Nasdaq
- Market Cap
- SNY 116.1B
- BX 132.8B
- IPO Year
- SNY N/A
- BX 2007
- Fundamental
- Price
- SNY $52.02
- BX $140.88
- Analyst Decision
- SNY Buy
- BX Buy
- Analyst Count
- SNY 4
- BX 16
- Target Price
- SNY $61.50
- BX $177.81
- AVG Volume (30 Days)
- SNY 2.3M
- BX 4.7M
- Earning Date
- SNY 10-24-2025
- BX 10-23-2025
- Dividend Yield
- SNY 3.07%
- BX 2.79%
- EPS Growth
- SNY 105.93
- BX 19.48
- EPS
- SNY 8.67
- BX 3.48
- Revenue
- SNY $53,890,648,839.00
- BX $12,791,218,000.00
- Revenue This Year
- SNY $2.37
- BX $4.18
- Revenue Next Year
- SNY $6.51
- BX $24.48
- P/E Ratio
- SNY $11.84
- BX $40.65
- Revenue Growth
- SNY N/A
- BX 14.84
- 52 Week Low
- SNY $44.62
- BX $115.66
- 52 Week High
- SNY $60.12
- BX $200.96
- Technical
- Relative Strength Index (RSI)
- SNY 63.33
- BX 32.48
- Support Level
- SNY $48.55
- BX $136.89
- Resistance Level
- SNY $52.68
- BX $146.69
- Average True Range (ATR)
- SNY 0.68
- BX 3.96
- MACD
- SNY 0.15
- BX 0.10
- Stochastic Oscillator
- SNY 85.01
- BX 26.76
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About BX Blackstone Inc.
Blackstone is the world's largest alternative-asset manager with $1.167 trillion in total asset under management, including $860.1 billion in fee-earning assets under management, at the end of March 2025. The company has four core business segments: private equity (26% of fee-earning AUM and 30% of base management fees), real estate (34% and 40%), credit and insurance (32% and 23%), and multi-asset investing (8% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).